US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist

3.7050
-0.1450-3.77%

Trading Dec 12 12:45 ET

574.81MMarket Cap-12.35P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

10M

49.21M

Operating revenue

--0

--10M

--1M

--0

--9M

--0

--49.21M

Cost of revenue

324.61%2.57M

-273K

-235K

3.43M

-347K

-104.74%-1.15M

24.17M

Gross profit

547.99%7.43M

1.27M

235K

5.57M

347K

-95.42%1.15M

25.04M

Operating expense

-0.79%9.15M

116.06%12.45M

-16.30%9.42M

-35.81%34.56M

8.32M

9.22M

5.76M

11.26M

1.02%53.84M

4.10%53.3M

Selling and administrative expenses

8.67%6.2M

194.79%7.87M

-8.43%5.91M

-29.43%18.42M

--3.6M

--5.71M

--2.67M

--6.45M

21.41%26.11M

-25.65%21.5M

-General and administrative expense

8.67%6.2M

194.79%7.87M

-8.43%5.91M

-29.43%18.42M

--3.6M

--5.71M

--2.67M

--6.45M

21.41%26.11M

-25.65%21.5M

Research and development costs

-11.80%3.17M

33.24%4.95M

-24.74%3.99M

-40.89%17.42M

--4.8M

--3.59M

--3.71M

--5.31M

-7.33%29.47M

42.72%31.8M

Other operating expenses

-175.61%-226K

40.58%-369K

4.41%-477K

25.93%-1.28M

---78K

---82K

---621K

---499K

---1.73M

----

Operating profit

-1.80%-9.15M

-6,450.00%-12.45M

13.64%-9.42M

48.51%-27.14M

-7.05M

-8.99M

-190K

-10.91M

-86.50%-52.7M

44.81%-28.26M

Net non-operating interest income expense

5,827.27%630K

134.76%228K

162.15%307K

77.51%-750K

410K

-11K

-656K

-494K

38.55%-3.34M

37.18%-5.43M

Non-operating interest income

42.67%983K

49.87%559K

101.63%617K

153.69%2.13M

--763K

--689K

--373K

--306K

62,138.96%840K

-80.19%1.35K

Non-operating interest expense

-49.57%353K

-67.83%331K

-61.25%310K

-30.99%2.88M

--353K

--700K

--1.03M

--800K

-22.68%4.18M

-37.92%5.4M

Total other finance cost

----

153.33%28.34K

Other net income (expense)

-363.04%-6.48M

95.80%-38K

124.59%165K

-116.13%-2.11M

-3M

2.47M

-905K

-671K

-75.25%13.1M

131.68%52.9M

Gain on sale of security

-363.04%-6.48M

95.80%-38K

124.81%165K

-117.50%-2.1M

---3M

--2.47M

---905K

---665K

-77.23%12.01M

134.66%52.75M

Special income (charges)

----

101.03%152.51K

-Gain on sale of property,plant,equipment

----

101.03%152.51K

Other non- operating income (expenses)

----

-100.92%-10K

---4K

----

---6K

--1.09M

----

Income before tax

-129.69%-15M

-599.89%-12.26M

25.88%-8.95M

30.14%-30M

-9.64M

-6.53M

-1.75M

-12.08M

-323.40%-42.94M

108.47%19.22M

Income tax

25.91%-532K

-532K

-135.09%-718K

153.20%2.05M

Net income

-129.69%-15M

-599.89%-12.26M

25.88%-8.95M

30.21%-29.47M

-9.11M

-6.53M

-1.75M

-12.08M

-345.83%-42.22M

107.70%17.17M

Net income continuous Operations

-129.69%-15M

-599.89%-12.26M

25.88%-8.95M

30.21%-29.47M

---9.11M

---6.53M

---1.75M

---12.08M

-345.83%-42.22M

107.70%17.17M

Minority interest income

Net income attributable to the parent company

-129.69%-15M

-599.89%-12.26M

25.88%-8.95M

30.21%-29.47M

-9.11M

-6.53M

-1.75M

-12.08M

-345.83%-42.22M

107.70%17.17M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-129.69%-15M

-599.89%-12.26M

25.88%-8.95M

30.21%-29.47M

-9.11M

-6.53M

-1.75M

-12.08M

-345.83%-42.22M

107.70%17.17M

Basic earnings per share

-100.00%-0.1

-617.77%-0.1

50.00%-0.05

42.86%-0.2

-0.05

-0.0139

-0.1

-359.33%-0.35

104.13%0.135

Diluted earnings per share

-100.00%-0.1

-617.77%-0.1

50.00%-0.05

42.86%-0.2

-0.05

-0.0139

-0.1

-3.73%-0.35

89.68%-0.3374

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	10M	1M	0	9M	0	0	49.21M
Operating revenue	--0	--0	--0	--10M	--1M	--0	--9M	--0	--0	--49.21M
Cost of revenue	0	0	0	324.61%2.57M	-273K	-235K	3.43M	-347K	-104.74%-1.15M	24.17M
Gross profit	0	0	0	547.99%7.43M	1.27M	235K	5.57M	347K	-95.42%1.15M	25.04M
Operating expense	-0.79%9.15M	116.06%12.45M	-16.30%9.42M	-35.81%34.56M	8.32M	9.22M	5.76M	11.26M	1.02%53.84M	4.10%53.3M
Selling and administrative expenses	8.67%6.2M	194.79%7.87M	-8.43%5.91M	-29.43%18.42M	--3.6M	--5.71M	--2.67M	--6.45M	21.41%26.11M	-25.65%21.5M
-General and administrative expense	8.67%6.2M	194.79%7.87M	-8.43%5.91M	-29.43%18.42M	--3.6M	--5.71M	--2.67M	--6.45M	21.41%26.11M	-25.65%21.5M
Research and development costs	-11.80%3.17M	33.24%4.95M	-24.74%3.99M	-40.89%17.42M	--4.8M	--3.59M	--3.71M	--5.31M	-7.33%29.47M	42.72%31.8M
Other operating expenses	-175.61%-226K	40.58%-369K	4.41%-477K	25.93%-1.28M	---78K	---82K	---621K	---499K	---1.73M	----
Operating profit	-1.80%-9.15M	-6,450.00%-12.45M	13.64%-9.42M	48.51%-27.14M	-7.05M	-8.99M	-190K	-10.91M	-86.50%-52.7M	44.81%-28.26M
Net non-operating interest income expense	5,827.27%630K	134.76%228K	162.15%307K	77.51%-750K	410K	-11K	-656K	-494K	38.55%-3.34M	37.18%-5.43M
Non-operating interest income	42.67%983K	49.87%559K	101.63%617K	153.69%2.13M	--763K	--689K	--373K	--306K	62,138.96%840K	-80.19%1.35K
Non-operating interest expense	-49.57%353K	-67.83%331K	-61.25%310K	-30.99%2.88M	--353K	--700K	--1.03M	--800K	-22.68%4.18M	-37.92%5.4M
Total other finance cost	----	----	----	----	----	----	----	----	----	153.33%28.34K
Other net income (expense)	-363.04%-6.48M	95.80%-38K	124.59%165K	-116.13%-2.11M	-3M	2.47M	-905K	-671K	-75.25%13.1M	131.68%52.9M
Gain on sale of security	-363.04%-6.48M	95.80%-38K	124.81%165K	-117.50%-2.1M	---3M	--2.47M	---905K	---665K	-77.23%12.01M	134.66%52.75M
Special income (charges)	----	----	----	----	----	----	----	----	----	101.03%152.51K
-Gain on sale of property,plant,equipment	----	----	----	----	----	----	----	----	----	101.03%152.51K
Other non- operating income (expenses)	----	----	----	-100.92%-10K	---4K	----	----	---6K	--1.09M	----
Income before tax	-129.69%-15M	-599.89%-12.26M	25.88%-8.95M	30.14%-30M	-9.64M	-6.53M	-1.75M	-12.08M	-323.40%-42.94M	108.47%19.22M
Income tax	0	0	0	25.91%-532K	-532K	0	0	0	-135.09%-718K	153.20%2.05M
Net income	-129.69%-15M	-599.89%-12.26M	25.88%-8.95M	30.21%-29.47M	-9.11M	-6.53M	-1.75M	-12.08M	-345.83%-42.22M	107.70%17.17M
Net income continuous Operations	-129.69%-15M	-599.89%-12.26M	25.88%-8.95M	30.21%-29.47M	---9.11M	---6.53M	---1.75M	---12.08M	-345.83%-42.22M	107.70%17.17M
Minority interest income
Net income attributable to the parent company	-129.69%-15M	-599.89%-12.26M	25.88%-8.95M	30.21%-29.47M	-9.11M	-6.53M	-1.75M	-12.08M	-345.83%-42.22M	107.70%17.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-129.69%-15M	-599.89%-12.26M	25.88%-8.95M	30.21%-29.47M	-9.11M	-6.53M	-1.75M	-12.08M	-345.83%-42.22M	107.70%17.17M
Basic earnings per share	-100.00%-0.1	-617.77%-0.1	50.00%-0.05	42.86%-0.2	-0.05	-0.05	-0.0139	-0.1	-359.33%-0.35	104.13%0.135
Diluted earnings per share	-100.00%-0.1	-617.77%-0.1	50.00%-0.05	42.86%-0.2	-0.05	-0.05	-0.0139	-0.1	-3.73%-0.35	89.68%-0.3374
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data